Eutilex Co., Ltd.
Records under this name other than the patents Eutilex Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Showing 1 to 4 of 4 · Back to Eutilex Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,396,555 | Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof Lapsed on the fee record Ended Jul 26, 2026 · High confidence | Lapsed on the fee record | Ended Jul 26, 2026 | High confidence |
| US 11,072,646 | Epitope for switching to TH1 cell and use thereof Lapsed on the fee record Ended Jul 27, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 27, 2025 | From the USPTO record |
| US 11,053,298 | Epitope for switching to TH2 cell and use thereof Lapsed on the fee record Ended Jul 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2025 | From the USPTO record |
| US 10,919,976 | IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof Lapsed on the fee record Ended Feb 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2025 | From the USPTO record |